Producers Online
Lánshæfismatsfyrirtækið Moody's Ratings (Moody's) hækkaði í dag lánshæfiseinkunnir íslenska ríkisins í innlendum og erlendum gjaldmiðlum í A1 úr A2. Horfur fyrir einkunnina eru stöðugar. Helsti drifkrafturinn fyrir hækkun lánshæfismatsins er…
Moody’s Ratings (Moody's) has upgraded the local and foreign-currency long-term issuer ratings of the Government of Iceland to A1 from A2 and changed the outlook to stable from positive. The…
TORONTO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- BULGOLD Inc. (TSXV: ZLTO) (the “Company” or “BULGOLD”) is pleased to provide a progress update on its Lutila Gold Project located in Central…
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Verses AI Inc. (CBOE:…
SINGAPORE, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it received a notice dated September…
Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant Approval based on…
Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement diagnostiqué, non éligibles à une transplantation Approbation fondée…
VANCOUVER, British Columbia, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR; OTCQB: BHILL) announces that it has elected to issue an…
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific and clinical advances that support optimal treatment options and decisions…
As a leader in neuroscience, Teva is committed to researching new treatment innovations that may help address unmet needs in treating schizophrenia, including TEV-‘749Currently, there is no long-acting olanzapine treatment…